Cochlear Implantation in Alport Syndrome: A Novel Case Series
View abstract on PubMed
Summary
This summary is machine-generated.Cochlear implantation (CI) successfully restored hearing in three patients with Alport syndrome, demonstrating significant improvements in speech perception and hearing thresholds. These findings suggest CI is a viable option for Alport syndrome-related hearing loss.
Area Of Science
- Otolaryngology
- Genetics
- Audiology
Background
- Alport syndrome is a genetic disorder affecting collagen, often leading to progressive sensorineural hearing loss.
- Hearing loss in Alport syndrome can significantly impact quality of life and communication.
Purpose Of The Study
- To evaluate the clinical outcomes of cochlear implantation (CI) in familial patients diagnosed with Alport syndrome.
- To assess the efficacy of CI in addressing progressive sensorineural hearing loss associated with Alport syndrome.
Main Methods
- A case series involving three familial patients (father and two daughters) with Alport syndrome who underwent cochlear implantation.
- Preoperative and postoperative audiological assessments, including pure-tone average (PTA), consonant-nucleus-consonant (CNC) scores, and Arizona Bioindustry Association (AzBio) scores, were utilized.
Main Results
- Patients demonstrated significant improvements in PTA, CNC, and AzBio scores post-implantation.
- One patient achieved 92% CNC and 87% AzBio scores 10 years after CI, while another showed 84% CNC and 62% AzBio scores at 3 months post-CI.
- The study highlights successful unilateral CI outcomes without complications in this patient cohort.
Conclusions
- Unilateral cochlear implantation is a safe and effective treatment for hearing loss in Alport syndrome.
- Further research into the efficacy of CI for individuals with Alport syndrome and other collagen-related disorders is warranted.

